BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 26371145)

  • 1. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
    King TA; Pilewskie M; Muhsen S; Patil S; Mautner SK; Park A; Oskar S; Guerini-Rocco E; Boafo C; Gooch JC; De Brot M; Reis-Filho JS; Morrogh M; Andrade VP; Sakr RA; Morrow M
    J Clin Oncol; 2015 Nov; 33(33):3945-52. PubMed ID: 26371145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.
    Sasson AR; Fowble B; Hanlon AL; Torosian MH; Freedman G; Boraas M; Sigurdson ER; Hoffman JP; Eisenberg BL; Patchefsky A
    Cancer; 2001 May; 91(10):1862-9. PubMed ID: 11346867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a low-grade precursor pathway in breast cancer?
    King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
    Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for women with lobular carcinoma in situ (LCIS).
    Oppong BA; King TA
    Oncology (Williston Park); 2011 Oct; 25(11):1051-6, 1058. PubMed ID: 22106556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S; Kestin LL; Goldstein NS; Vicini FA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ?
    Minami CA; Zabor EC; Gilbert E; Newman A; Park A; Jochelson MS; King TA; Pilewskie ML
    Ann Surg Oncol; 2020 Jun; 27(6):1844-1851. PubMed ID: 31898097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
    Wong SM; King T; Boileau JF; Barry WT; Golshan M
    Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy.
    Abner AL; Connolly JL; Recht A; Bornstein B; Nixon A; Hetelekidis S; Silver B; Harris JR; Schnitt SJ
    Cancer; 2000 Mar; 88(5):1072-7. PubMed ID: 10699897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: is re-excision necessary?
    Sadek BT; Shenouda MN; Abi Raad RF; Niemierko A; Keruakous AR; Goldberg SI; Taghian AG
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):726-30. PubMed ID: 24064317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ.
    Miller ME; Muhsen S; Zabor EC; Flynn J; Olcese C; Giri D; Van Zee KJ; Pilewskie M
    Ann Surg Oncol; 2019 Dec; 26(13):4317-4325. PubMed ID: 31552614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary results: double lumpectomies for multicentric breast carcinoma.
    Kapoor NS; Chung A; Huynh K; Giuliano AE
    Am Surg; 2012 Dec; 78(12):1345-8. PubMed ID: 23265123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobular carcinoma in situ as a component of breast cancer: the long-term outcome in patients treated with breast-conservation therapy.
    Moran M; Haffty BG
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):353-8. PubMed ID: 9457821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobular carcinoma in situ: observation without surgery as an appropriate therapy.
    Carson W; Sanchez-Forgach E; Stomper P; Penetrante R; Tsangaris TN; Edge SB
    Ann Surg Oncol; 1994 Mar; 1(2):141-6. PubMed ID: 7834439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pathologic Finding of Combined Lobular Carcinoma
    Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
    Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.
    Cutuli B; De Lafontan B; Kirova Y; Auvray H; Tallet A; Avigdor S; Brunaud C; Delva C
    Radiat Oncol; 2015 May; 10():110. PubMed ID: 25944033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.
    De Brot M; Koslow Mautner S; Muhsen S; Andrade VP; Mamtani A; Murray M; Giri D; Sakr RA; Brogi E; King TA
    Breast Cancer Res Treat; 2017 Sep; 165(2):411-420. PubMed ID: 28612228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma.
    Wallace AS; Xiang D; Hockman L; Arya M; Jeffress J; Wang Z; Dale PS
    Eur J Surg Oncol; 2014 Oct; 40(10):1245-9. PubMed ID: 24857380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in incidence and management of lobular carcinoma in situ: a population-based analysis.
    Portschy PR; Marmor S; Nzara R; Virnig BA; Tuttle TM
    Ann Surg Oncol; 2013 Oct; 20(10):3240-6. PubMed ID: 23846782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.